PL2704698T3 - Postać leku do kontrolowanego uwalniania substancji czynnych - Google Patents
Postać leku do kontrolowanego uwalniania substancji czynnychInfo
- Publication number
- PL2704698T3 PL2704698T3 PL12719667T PL12719667T PL2704698T3 PL 2704698 T3 PL2704698 T3 PL 2704698T3 PL 12719667 T PL12719667 T PL 12719667T PL 12719667 T PL12719667 T PL 12719667T PL 2704698 T3 PL2704698 T3 PL 2704698T3
- Authority
- PL
- Poland
- Prior art keywords
- dosage form
- active ingredients
- controlled release
- release
- ingredients
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 239000002552 dosage form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE201110075354 DE102011075354A1 (de) | 2011-05-05 | 2011-05-05 | Arzneiform zur gezielten Freigabe von Wirkstoffen |
| DE102011075356 | 2011-05-05 | ||
| PCT/EP2012/057996 WO2012150246A1 (de) | 2011-05-05 | 2012-05-02 | Arzneiform zur gezielten freigabe von wirkstoffen |
| EP12719667.3A EP2704698B1 (de) | 2011-05-05 | 2012-05-02 | Arzneiform zur gezielten freigabe von wirkstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2704698T3 true PL2704698T3 (pl) | 2020-01-31 |
Family
ID=46046170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12719667T PL2704698T3 (pl) | 2011-05-05 | 2012-05-02 | Postać leku do kontrolowanego uwalniania substancji czynnych |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2704698B1 (pl) |
| EA (1) | EA025128B1 (pl) |
| ES (1) | ES2755075T3 (pl) |
| HU (1) | HUE047420T2 (pl) |
| LT (1) | LT2704698T (pl) |
| PL (1) | PL2704698T3 (pl) |
| PT (1) | PT2704698T (pl) |
| WO (1) | WO2012150246A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX370067B (es) * | 2012-12-27 | 2019-11-29 | Hennig Arzneimittel Gmbh & Co | Forma de dosis monolítica para liberación modificada de una combinación de ingredientes activos. |
| LT2959887T (lt) | 2014-06-26 | 2019-03-12 | Hennig Arzneimittel Gmbh&Co. Kg | Vaistai galvos svaigimo, atsiradusio dėl įvairių priežasčių, gydymui |
| WO2018115888A1 (en) * | 2016-12-21 | 2018-06-28 | N4 Pharma Uk Limited | Novel formulations of aprepitant |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5262173A (en) | 1992-03-02 | 1993-11-16 | American Cyanamid Company | Pulsatile once-a-day delivery systems for minocycline |
| WO1999012524A1 (en) | 1997-09-11 | 1999-03-18 | Nycomed Danmark A/S | MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| US20020054911A1 (en) * | 2000-05-11 | 2002-05-09 | Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi | Novel oral dosage form for carvedilol |
| US7374779B2 (en) * | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| US6955821B2 (en) * | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
| US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| EP2112920B1 (en) * | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| GB2414668B (en) | 2004-06-03 | 2009-07-29 | Dexcel Ltd | Tetracycline modified release delivery system |
| AR062647A1 (es) * | 2005-01-21 | 2008-11-26 | Pharmanova Inc | Formulaciones farmaceutica y metodos de uso |
| DE102005014142B4 (de) | 2005-03-23 | 2006-11-09 | Hennig Arzneimittel Gmbh & Co. Kg | Pelletförmige Retardzubereitung gegen Schwindel |
| WO2006099886A1 (de) | 2005-03-24 | 2006-09-28 | Eska Implants Gmbh & Co. | Set zur erstellung eines grosszehengrundgelenkes |
| CA2612727A1 (en) | 2005-05-13 | 2006-11-23 | Alpharma, Inc. | Morphine sulfate formulations |
| WO2007083323A2 (en) * | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
| AU2006337643A1 (en) * | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Dipyridamole extended-release formulations and process for preparing same |
-
2012
- 2012-05-02 WO PCT/EP2012/057996 patent/WO2012150246A1/de not_active Ceased
- 2012-05-02 PT PT127196673T patent/PT2704698T/pt unknown
- 2012-05-02 EA EA201301232A patent/EA025128B1/ru unknown
- 2012-05-02 ES ES12719667T patent/ES2755075T3/es active Active
- 2012-05-02 LT LT12719667T patent/LT2704698T/lt unknown
- 2012-05-02 HU HUE12719667A patent/HUE047420T2/hu unknown
- 2012-05-02 EP EP12719667.3A patent/EP2704698B1/de active Active
- 2012-05-02 PL PL12719667T patent/PL2704698T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2755075T3 (es) | 2020-04-21 |
| EP2704698A1 (de) | 2014-03-12 |
| WO2012150246A1 (de) | 2012-11-08 |
| PT2704698T (pt) | 2019-11-19 |
| EA025128B1 (ru) | 2016-11-30 |
| EA201301232A1 (ru) | 2014-03-31 |
| LT2704698T (lt) | 2019-11-25 |
| EP2704698B1 (de) | 2019-10-02 |
| HUE047420T2 (hu) | 2020-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201307862B (en) | Controlled release pharmaceutical dosage forms | |
| ZA201403795B (en) | Formulations for the treatment of diabetes | |
| IL238713A0 (en) | Self-regulating active pharmaceutical ingredient release | |
| PT2734536T (pt) | Processo para a preparação de estetrol | |
| ZA201404035B (en) | Microcapsule containing fungicidal active ingredient | |
| IL236465A0 (en) | Pharmaceutical composition for delayed release of active substances | |
| IL236466B (en) | Pharmaceutical composition for the release of active components | |
| PT2846839T (pt) | Formulações para a administração de ingredientes ativos | |
| ZA201207397B (en) | Process for the preparation of dexlansoprazole | |
| SMT201800128T1 (it) | Composti farmaceuticamente attivi | |
| PL2704698T3 (pl) | Postać leku do kontrolowanego uwalniania substancji czynnych | |
| IL239670B (en) | Monolithic administration form for delayed release of a combination of active substances | |
| HUP1100290A2 (en) | Combination compositions for the treatment of proliferative diseases | |
| ZA201309732B (en) | Process for the preparation of dexlansoprazole | |
| HUP1100240A2 (en) | Novel coupling process for the preparation of pharmeceutically active ingredient | |
| HUP1100245A2 (en) | Pharmaceutical composition for the treatment of wounds | |
| IL232294A0 (en) | Preparations for the treatment of diabetes | |
| GB201113730D0 (en) | Solid dosage form | |
| AP2015008270A0 (en) | Preparation for the treatment of tuberculosis |